⌘K
Loading ticker…
Ocugen, Inc. Common Stock · Healthcare · Pharmaceutical Products
As of 2026-06-26, Ocugen, Inc. Common Stock (OCGN) has a 3-month relative strength percentile of 15 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 48. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 6.3%, relative volume 8.38×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
15 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
OCGN is in a stage 3 topping pattern, week 2. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: 2.9% / -2.6%.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
OCGN is held by 4 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $18M notional. Top 3 carry $34M.
Top 4 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $18M |
| XBIState Street SPDR S&P Biotech ETF | 0.13% | $9M |
| VXFVanguard Extended Market ETF | 0.01% | $7M |
| ITOTiShares Core S&P Total U.S. Stock Market ETF | 0.00% | $1M |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | OCGN Jan avg: -2.83% median: -4.55% win: 25% σ: 7.47% n: 4 2022-04-12 → 2026-05-29 | OCGN Feb avg: 17.05% median: 7.56% win: 50% σ: 43.34% n: 4 2022-04-12 → 2026-05-29 | OCGN Mar avg: 17.17% median: 3.91% win: 50% σ: 39.81% n: 4 2022-04-12 → 2026-05-29 | OCGN Apr avg: -11.79% median: -16.35% win: 20% σ: 12.30% n: 5 2022-04-12 → 2026-05-29 | OCGN May avg: -0.92% median: 8.22% win: 60% σ: 26.66% n: 5 2022-04-12 → 2026-05-29 | OCGN Jun avg: 4.88% median: 5.92% win: 50% σ: 14.32% n: 4 2022-04-12 → 2026-05-29 (current) | OCGN Jul avg: 5.92% median: 9.69% win: 75% σ: 10.75% n: 4 2022-04-12 → 2026-05-29 | OCGN Aug avg: -9.59% median: -4.22% win: 0% σ: 13.94% n: 4 2022-04-12 → 2026-05-29 | OCGN Sep avg: -0.52% median: -15.45% win: 25% σ: 41.43% n: 4 2022-04-12 → 2026-05-29 | OCGN Oct avg: -5.97% median: -6.16% win: 0% σ: 2.50% n: 4 2022-04-12 → 2026-05-29 | OCGN Nov avg: -4.23% median: -2.10% win: 50% σ: 13.20% n: 4 2022-04-12 → 2026-05-29 | OCGN Dec avg: 5.72% median: -3.90% win: 50% σ: 31.21% n: 4 2022-04-12 → 2026-05-29 |